The upregulation of LINC01123, which targets microRNA regulating B7-H3, miR-214-3p, leads to the inhibition of CD8+ T-cell activation, thereby promoting tumor growth through the upregulation of B7-H3 expression in HNSCC [178]. The gene discussed is CD8A; the disease is neoplasm.